News|Articles|May 13, 2024
Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends
Author(s)Pfizer CentreOne
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
3
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5